Covid-19
- Update in cutaneous manifestations of COVID-19: Special populations
Recognition of skin reactions and their implications is beneficial to clinicians in shaping patient counseling and anticipatory guidance. An illustrated guide.
- Common skin signs of COVID-19 in adults: An update
Cutaneous findings can be clues to the diagnosis and infection severity in viral illnesses, including COVID-19.
- A perspective on discussing COVID-19 vaccines: Efficacy and adverse effects
Physicians should be vigilant and open-minded regarding possible adverse reactions to the vaccines, and should take time to discuss the demonstrated efficacy of vaccines with patients.
- COVID-19 vaccine-induced cellulitis and myositis
The day after receiving the second dose of the mRNA vaccine, redness and pain developed at the injection site, eventually involving the whole left arm and shoulder.
- Neuropsychiatric assessment and management of the ICU survivor
Post-intensive care syndrome occurs in 50% to 70% of ICU survivors. The authors examine various facets of this syndrome and emphasize the role of post-ICU recovery clinics.
- Another influenza season in the shadow of the COVID-19 pandemic
Flu season is upon us at the ominous milestone of more than 722,000 US deaths from COVID-19.
- The initial viral infection may be only part of the story
We clearly see that the coronavirus elicits syndromes far afield from respiratory tissues. But a virus eliciting effects seemingly distinct from the primary infection is nothing new.
- Dermatomyositis-related interstitial lung disease mimicking COVID-19 pneumonia
A subtype of myositis with characteristic skin rashes and ulcers, amyopathic or hypomyopathic symptoms, and rapidly progressive ILD.